FDA Drafts Guidance on Replacing Reagents for IVD Devices Post author:Sam Post published:February 15, 2018 Post category:The GMP Letter The FDA issued draft guidance to provide updates on in vitro diagnostics’ replacement reagents. Source: The GMP Letter You Might Also Like SynCardia Systems Nailed for MDR Deficiencies May 15, 2018 UK Introduces New Legislation to Overhaul Medical Device Authority March 6, 2020 EU Rolls Out New Guidance on Cybersecurity January 14, 2020